Burkitt Lymphoma and Leukemia

New Chemotherapy Regimen Produces Long-Term, Disease-Free Survival

Published in Cancer Weekly, November 6th, 2001

Brief, intense cycles of high-dose chemotherapy produced long-term, disease-free survival in more than half of adults treated for Burkitt small non-cleaved lymphoma and Burkitt leukemia, researchers from the Cancer and Acute Leukemia Group B report.

Burkitt lymphoma, also known as small noncleaved-cell lymphoma, is a fast-growing form of non-Hodgkin lymphoma (NHL) that most often occurs in young people aged 12-30 years. Burkitt's leukemia, also known as B-cell acute lymphocytic leukemia, is the rarest form of acute lymphocytic leukemia (ALL).

These study findings represent an important treatment advance for these two similar, highly aggressive...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2001-11-06)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry